首页> 美国卫生研究院文献>Arthritis Research >Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study

【2h】

Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study

机译：接受风湿性疾病生物治疗的HBsAg阴性/ HBcAb阳性患者的乙型肝炎病毒表面抗体滴度变化和乙型肝炎再激活的风险：一项前瞻性队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundOur aim was to investigate dynamic changes in hepatitis B virus (HBV) surface antibody (HBsAb) titer and the associated risk of HBV reactivation and clinical course in patients with HBV surface antigen negative/core antibody positive (HBsAg⁻/HBcAb⁺) serostatus during antirheumatic therapy with biologic agents.

机译：背景我们的目的是调查HBV表面抗原阴性/核心抗体阳性（HBsAg ^{− / HBcAb ^{+ ）在使用生物制剂进行抗风湿治疗期间的血清状态。}}

著录项

期刊名称 Arthritis Research
作者
Ya-Chih Tien; Hsu-Heng Yen; Ching-Fang Li; Mei-Ping Liu; Yin-Tzu Hsue; Ming-Hui Hung; Ying-Ming Chiu;
展开▼
作者单位

展开▼
年(卷),期 2018(20),-1
年度 2018
页码 246
总页数 8
原文格式 PDF
正文语种
中图分类外科学;
关键词
DMARDs (biologic) Hepatitis B virus surface/core antibody (HBsAb/HBcAb) Rheumatic diseases HBV reactivation;

机译：DMARD（生物的）;乙型肝炎病毒表面/核心抗体（HBsAb / HBcAb）;风湿性疾病;HBV激活;

相似文献

外文文献
中文文献
专利

1. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study [J] . Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Arthritis research & therapy. . 2018,第1期

机译：接受风湿性疾病生物治疗的HBsAg阴性/ HBcAb阳性患者的乙型肝炎病毒表面抗体滴度变化和乙型肝炎再激活的风险：一项前瞻性队列研究
2. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study. [J] . Ji D, Cao J, Hong X, European Journal of Haematology . 2010,第3期

机译：多中心回顾性研究显示，在HBsAg阴性/ HBcAb阳性的弥漫性大B细胞淋巴瘤患者中，化疗期间乙型肝炎病毒重新激活的发生率较低。
3. Do low titers of antibody against hepatitis B surface antigen carry a risk of viral reactivation during immunosuppressive therapy for rheumatic diseases? [J] . MoriS. The Journal of rheumatology . 2012,第6期

机译：在针对风湿性疾病的免疫抑制治疗过程中，低滴度的抗乙型肝炎表面抗原抗体是否具有病毒再激活的风险？
4. Herbal Medicine Containing Aristolochic Acid and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection: A Nationwide Population-Based Cohort Study in Taiwan [C] . Wen-Chao Ho, Chi-Jen Chen, Yao-Hsu Yang, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：含有马兜铃酸的草药和丙型肝炎病毒感染患者肝细胞癌的风险：台湾全国性人群研究
5. Hepatitis virus reactivation in cancer patients undergoing cytotoxic chemotherapy: Incidences, associated factors and management. [D] . Yeo, Winnie. 2001

机译：接受细胞毒性化学疗法治疗的癌症患者的肝炎病毒再激活：发生率，相关因素和管理。
6. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study [O] . Jessica P. Hwang, Anna S. Lok, Michael J. Fisch, -1

机译：进行系统性抗癌治疗的癌症患者中预测乙型肝炎病毒感染的模型：一项前瞻性队列研究
7. Do Low Titers of Antibody Against Hepatitis B Surface Antigen Carry a Risk of Viral Reactivation During Immunosuppressive Therapy for Rheumatic Diseases? [O] . SHUNSUKE MORI 2012

机译：对乙型肝炎表面抗原的抗体的低滴度是否在免疫抑制治疗中对风湿性疾病进行病毒重新激活的风险？

Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study

摘要

著录项

相似文献

相关主题

期刊订阅